Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 2/20 | 0.57 |
| ▸ | MAG | P20916 | 5/20 | 0.56 |
| ▸ | SELL | P14151 | 1/20 | 0.55 |
| ▸ | SELP | P16109 | 1/20 | 0.55 |
| ▸ | NANP | Q8TBE9 | 1/20 | 0.53 |
| ▸ | CD22 | P20273 | 11/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29437857 | 1.00 | SIGLEC7 (0.57) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29883057 | 1.00 | SIGLEC7 (0.57) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29437858 | 1.00 | SIGLEC7 (0.57) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29397098 | 1.00 | SIGLEC7 (0.57) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29410578 | 0.94 | SIGLEC7 (0.55) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL16298815 | 0.94 | SIGLEC7 (0.55) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29352702 | 0.94 | SIGLEC7 (0.55) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL15177450 | 0.94 | SIGLEC7 (0.55) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL29732933 | 0.94 | SIGLEC7 (0.55) | SIGLEC7MAGSELLSELPNANP | |
| SCHEMBL17300136 | 0.93 | MAG (0.56) | SIGLEC7MAGSELLSELPNANP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250136683-A1 | Method of modulating autoimmunity by disrupting cis-ligand binding of siglec type antigens | SINOMAB BIOSCIENCE LIMITED (HK) | 2025-05-01 | — | — | US | disclosed |
| US-12173065-B2 | Fusion proteins comprising extracellular domain of human CD22 | SINOMAB BIOSCIENCE LIMITED (HK) | 2024-12-24 | — | — | US | disclosed |